bromodeoxyuridine has been researched along with aflatoxin b1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bloom, SE; Dietert, RR; Nanna, UC; Qureshi, MA | 1 |
Augusti-Tocco, G; Cacci, E; Gensabella, G; Ricordy, R | 1 |
Gursoy-Yuzugullu, O; Ozturk, M; Yilmaz, M; Yuzugullu, H | 1 |
Guo, L; Jiang, W; Kang, C; Li, L; Liu, Q; Su, D; Xiao, C; Xu, C; Yang, C; Yuan, Q; Zhang, J; Zhang, M; Zhou, T | 1 |
4 other study(ies) available for bromodeoxyuridine and aflatoxin b1
Article | Year |
---|---|
Embryonic exposure to aflatoxin-B1: mutagenicity and influence on development and immunity.
Topics: Aflatoxin B1; Aflatoxins; Animals; Antibody Formation; Bromodeoxyuridine; Cell Cycle; Chick Embryo; Female; Immunity; Immunity, Cellular; Male; Mutation; Sister Chromatid Exchange | 1985 |
Impairment of cell cycle progression by aflatoxin B1 in human cell lines.
Topics: Aflatoxin B1; Blotting, Western; Bromodeoxyuridine; Carcinogens; Cell Cycle; Cell Line; Cyclic AMP; Flow Cytometry; Humans; Multivariate Analysis; Mutation; Proto-Oncogene Proteins p21(ras); Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation.
Topics: Aflatoxin B1; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Line, Tumor; Comet Assay; DNA Damage; Doxorubicin; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Liver Neoplasms; Mutagenicity Tests; Mutation; Phosphorylation; Tumor Suppressor Protein p53 | 2011 |
Chronic exposure to aflatoxin B1 increases hippocampal microglial pyroptosis and vulnerability to stress in mice.
Topics: Aflatoxin B1; Animals; Bromodeoxyuridine; Depressive Disorder, Major; Hippocampus; Mice; Microglia; Pyroptosis; Sucrose | 2023 |